AZD2820

AstraZeneca halts development of anti-obesity drug
Marketwatch
Mon, 09/10/12 - 11:23 am
obesity
Palatin
AstraZeneca
AZD2820
AZ halts obesity drug trial, completes Ardea purchase
Pharma Times, UK
Wed, 06/20/12 - 12:32 pm
obesity
M&A
Ardea Biosciences
AstraZeneca
AZD2820